Graduate students, doctoral candidates and postdoctoral fellows at the Center for BrainHealth compete for $25,000 research grants that are awarded at the annual Friends of BrainHealth Scientist Selection Luncheon. This year, the luncheon was held October 7 at Dallas Country Club and sponsored by Visionary Friends Katherine and Bob Penn.
2015 Friends of BrainHealth co-chairs Lucy and Lindsay Billingsley led the charge because they felt “the greatest contribution that we can each make to the world is to leverage innovative thinking.” The fundraising year supported five awards to exceptional neuroscientists who are already making their mark on the field of brain science at this early point in their careers. Their work will contribute to the foundation of future medical and scientific breakthroughs and advance the Center for BrainHealth’s mission to understand, protect and heal the brain.
Linda and Joel Robuck joined Friends of BrainHealth at the Visionary Friend Level for the fourth year in a row and chose to further a study that investigates the biological causes of social impairments.
“We truly believe Adam’s work to augment the complex nature and understanding of social impairments, in an effort to enhance the lives of the individuals and families affected, is deeply paramount to the future of brain science, this community and our nation as a whole,” said Joel Robuck.
Under the guidance of faculty member Dr. Daniel Krawczyk, Adam Teed will investigate the possibility that oxytocin and vasopressin, two hormones that have been scientifically implicated in empathizing with others, might have a broad influence on social motivation. Using functional magnetic resonance imaging (fMRI), Adam aims to reveal the patterns of brain activity associated with social preferences and values, opening the doors for new treatments based on hormonal systems to increase quality of life for those that suffer from social dysfunctions.
Katherine and Bob Penn awarded their second $25,000 grant to Dr. Jenny Meier whose research will investigate adding two elements to the Center for BrainHealth’s scientifically validated strategy-based cognitive training program called Strategic Memory Advanced Reasoning Tactics, or SMART™. Her work, under the direction of the Center’s founder and chief director, Dr. Sandra Bond Chapman, will explore whether combining a pharmaceutical dopaminergic agent or transcranial direct current stimulation (tDCS ) with SMART will enhance gains in innovative thinking and psychological health to a greater degree than traditional SMART with veterans who have sustained brain injuries.
“Katherine and I are excited to back Dr. Jenny Meier in her ongoing effort to enhance both the critical thinking and the psychological health of our nation’s warriors,” said Bob Penn. “The Center for BrainHealth’s SMART program has done so much for this special group of heroes and heroines and it’s wonderful to think that there may be ways to make it even more effective with pharmaceuticals or direct current stimulation!”
Kate Juett, chair of the Sapphire Foundation, Inc. board of directors said, “Sapphire feels most fortunate to be able to support Dr. Chiang in this significant research project. He is very accomplished in this area and this research will hopefully foster more insight into this devastating disease that continues to affect so many of our families, friends and our society.”
Friends of BrainHealth members listened to research proposal presentations from three finalists at the annual luncheon and voted to award the final grant.
Matthew Kmiecik, a doctoral student of Dr. Krawczyk and first time finalist, was selected as the member favorite for his study that will utilize EEG brain wave measurements to examine the changeability of automatic, pre-conscious processes that inform later, higher-level conscious processes in individuals who have suffered a traumatic brain injury.
After the luncheon an anonymous donor awarded a grant to finalist Dr. Kihwan Han, a member of Dr. Krawczyk’s lab, for his research that seeks to create a method to objectively measure brain injury recovery using cortical thickness as a measure of cognitive health.
“It is always brain-inspiring to be in the presence of a magnanimous, philanthropic community that supports young scientists and their leading-edge approaches to scientific discovery,” said Chapman. “Because of Dallas visionary donors over the years, our doctoral students and research fellows have been able to conduct and publish groundbreaking studies in multiple sclerosis, traumatic brain injury, depression and Alzheimer’s disease. We are beholden to each BrainHealth Friend for their selfless generosity and dedication to our mission.”